VEGFB and type 2 diabetes mellitus: Genetic Vegfb deletion (Vegfb−/−), or pharmacological inhibition of VEGF-B signaling using neutralizing antibodies, in a T2DM mouse model (db/db)13 restored insulin sensitivity and improved glucose tolerance correlating with preserved islet architecture and improved β-cell function.